Pfizer Says Third COVID Vaccine Dose Effective Against Omicron Variant
A new study by Pfizer-BioNTech found that a third dose of their COVID-19 vaccine is effective against the emerging omicron variant. The pharmaceutical giants also look to manufacture a vaccine specific to the omicron variant by March 2022.
Ryan Louvar, Chief Policy Officer and Head of Business and Legal Affairs, Digital Assets at WisdomTree, breaks down the CLARITY Act and crypto’s next phase.
KFC U.S. President Catherine Tan-Gillespie breaks down Open House, the new hospitality-first concept meant to reinvent the Colonel for today's consumers.
New Crunch Fitness CEO Chequan Lewis discusses Crunch 3.0, blending boutique fitness, recovery wellness and digital training into an accessible gym model.
